We are live on ! Find out more
DRZID

DePrince Race & Zollo Inc (DRZ) Portfolio holdings

AUM $5.29B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
-6.13%
1 Year Est. Return
+20.14%
3 Year Est. Return
+36.34%
5 Year Est. Return
+39.16%
10 Year Est. Return
+157.08%
AUM
$7.4B
AUM Growth
-$1.12B
Cap. Flow
-$592M
Cap. Flow %
-8%
Top 10 Hldgs %
13.14%
Holding
336
New
39
Increased
75
Reduced
165
Closed
54

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$88.5M
2
PX
Praxair Inc
PX
+$71.2M
3
KO icon
Coca-Cola
KO
+$67.1M
4
WBA
Walgreens Boots Alliance
WBA
+$51.4M
5
FLO icon
Flowers Foods
FLO
+$49.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$100M
2
URS
URS CORP
URS
+$86.4M
3
NTRS icon
Northern Trust
NTRS
+$82M
4
BNY
Bank of New York Mellon
BNY
+$78.1M
5
KSS icon
Kohl's
KSS
+$62.7M

Sector Composition

Rank Sector Weight
1 Financials 23.45%
2 Consumer Discretionary 14.54%
3 Industrials 14.15%
4 Energy 10.59%
5 Technology 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFC
251
Ellington Financial
EFC
$1.76B
$1.59M 0.02%
+71,500
New +$1.7M
LMNR icon
252
Limoneira
LMNR
$251M
$1.56M 0.02%
66,046
-42,266
-39% -$971K
RWT
253
Redwood Trust
RWT
$592M
$1.56M 0.02%
+94,000
New +$1.78M
RCAP
254
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
$1.54M 0.02%
68,553
-238,147
-78% -$5.25M
CIB icon
255
Grupo Cibest SA
CIB
$22.6B
$1.48M 0.02%
26,110
+17,410
+200% +$1.07M
MTOR
256
DELISTED
MERITOR, Inc.
MTOR
$1.44M 0.02%
132,300
+49,000
+59% +$638K
TEVA icon
257
Teva Pharmaceuticals
TEVA
$42.8B
$1.31M 0.02%
24,330
-837,201
-97% -$44.4M
PBR.A icon
258
Petrobras Class A
PBR.A
$103B
$1.27M 0.02%
85,050
+44,400
+109% +$790K
EWT icon
259
iShares MSCI Taiwan ETF
EWT
$11.4B
$1.2M 0.02%
39,383
-6,612
-14% -$212K
IXYS
260
DELISTED
IXYS Corp
IXYS
$1.13M 0.02%
107,930
-786,109
-88% -$9.23M
RICK icon
261
RCI Hospitality Holdings
RICK
$214M
$1.06M 0.01%
95,794
+9,400
+11% +$107K
SGBK
262
DELISTED
Stonegate Bank
SGBK
$1.03M 0.01%
+40,079
New +$1.02M
EPI icon
263
WisdomTree India Earnings Fund ETF
EPI
$2.04B
$995K 0.01%
+45,400
New +$1.02M
IBN icon
264
ICICI Bank
IBN
$107B
$982K 0.01%
110,000
+55,550
+102% +$519K
VVTV
265
DELISTED
VALUEVISION MEDIA INC
VVTV
$915K 0.01%
+178,400
New +$869K
VSI
266
DELISTED
Vitamin Shoppe Inc.
VSI
$910K 0.01%
+20,500
New +$860K
GGB icon
267
Gerdau
GGB
$9.48B
$907K 0.01%
238,014
+135,450
+132% +$620K
AMC icon
268
AMC Entertainment Holdings
AMC
$2.26B
$839K 0.01%
+3,650
New +$860K
REI icon
269
Ring Energy
REI
$354M
$817K 0.01%
55,448
-17,008
-23% -$291K
OAKS
270
DELISTED
Five Oaks Investment Corp.
OAKS
$767K 0.01%
73,000
-27,000
-27% -$301K
GST
271
DELISTED
Gastar Exploration Inc.
GST
$766K 0.01%
+130,545
New +$959K
PDS
272
Precision Drilling
PDS
$1.08B
$761K 0.01%
3,525
+1,025
+41% +$255K
PDCE
273
DELISTED
PDC Energy, Inc.
PDCE
$754K 0.01%
+15,000
New +$845K
MRC
274
DELISTED
MRC Global
MRC
$704K 0.01%
30,200
+8,500
+39% +$218K
AKS
275
DELISTED
AK Steel Holding Corp
AKS
$661K 0.01%
82,500
-24,100
-23% -$225K

Similar funds

DePrince Race & Zollo Inc (DRZ)'s Q3 2014 Portfolio in Review

As of Q3 2014, DePrince Race & Zollo Inc (DRZ) held 336 positions worth $7.4B, down 13% from $8.52B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

DePrince Race & Zollo Inc (DRZ) withdrew a net $592M in Q3 2014, closing 54 positions and reducing 165 holdings. Its most notable exit was Amgen, an estimated $100M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, DePrince Race & Zollo Inc (DRZ) opened a new position in Pfizer worth $88.5M.

  • DePrince Race & Zollo Inc (DRZ)'s largest Q3 2014 buy was Pfizer: 3,153,779 shares worth $88.5M.
  • DePrince Race & Zollo Inc (DRZ) added most to Emerson Electric in Q3 2014, an estimated $34.5M increase.
  • DePrince Race & Zollo Inc (DRZ)'s biggest Q3 2014 reduction was Teva Pharmaceuticals, cutting an estimated $44.4M.
  • DePrince Race & Zollo Inc (DRZ) fully exited Amgen in Q3 2014, selling an estimated $100M.
  • DePrince Race & Zollo Inc (DRZ)'s ten largest holdings make up 13% of its $7.4B portfolio in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ) opened 39 new positions and closed 54 in Q3 2014.
  • DePrince Race & Zollo Inc (DRZ)'s portfolio value fell 13% quarter-over-quarter to $7.4B.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q3 2014, filed 30 Oct 2014.